<?xml version="1.0" encoding="UTF-8"?>
<p>Treating infected persons with combination ART dramatically reduces their likelihood of transmitting HIV to an uninfected partner. The efficacy of this strategy known as ‘Treatment as Prevention (TasP)’ is illustrated by several studies. HPTN 052 trial
 <xref rid="ref17" ref-type="bibr">17</xref>
 <xref rid="ref18" ref-type="bibr">18</xref> demonstrated that early ART reduced the risk of heterosexual HIV transmission by 96 per cent in discordant couples. In India, early ART was cost-effective over a 5-year period and very cost-effective over a lifetime
 <xref rid="ref19" ref-type="bibr">19</xref>. A recent modelling study in India suggested that in the presence of existing condom-based interventions, existing ART programmes could avert 11-28 per cent of remaining HIV infections in FSW between 2014 and 2024
 <xref rid="ref20" ref-type="bibr">20</xref>.
</p>
